ANDA 70035, held by Watson Laboratories. Metronidazole.
As of Nov 21, 2026, ANDA 70035 (Metronidazole), held by Watson Laboratories, was first approved by FDA on Dec 20, 1984, with 44 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 20, 1984 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Metronidazole250MG · tablet;oral | Metronidazole | Rx |
| Oct 10, 2024 | Supplement 64Labeling · Standard review | Approved | None posted |
| Jul 8, 2024 | Supplement 63Labeling · Standard review | Approved | None posted |
| Jun 20, 2024 | Supplement 62Labeling · Standard review | Approved | None posted |
| Apr 5, 2022 | Supplement 61Labeling · Standard review | Approved | None posted |
| Apr 5, 2022 | Supplement 60Labeling · Standard review | Approved | None posted |
| Aug 13, 2019 | Supplement 59Labeling · Standard review | Approved | None posted |
| Jun 30, 2014 | Supplement 57Labeling · Standard review | Approved | None posted |
| Aug 2, 2013 | Supplement 56Labeling · Standard review | Approved | None posted |
| Aug 30, 2001 | Supplement 42Manufacturing | Approved | None posted |
| Jul 7, 2000 | Supplement 39Manufacturing | Approved | None posted |
| Mar 23, 2000 | Supplement 38Manufacturing | Approved | None posted |
| Jun 8, 1998 | Supplement 37Manufacturing | Approved | None posted |
| Aug 28, 1997 | Supplement 35Manufacturing | Approved | None posted |
| Jul 8, 1997 | Supplement 34Manufacturing | Approved | None posted |
| Mar 6, 1997 | Supplement 36Labeling | Approved | None posted |
| Aug 16, 1996 | Supplement 33Manufacturing | Approved | None posted |
| Feb 5, 1996 | Supplement 32Manufacturing | Approved | None posted |
| Nov 14, 1995 | Supplement 31Labeling | Approved | None posted |
| Oct 3, 1995 | Supplement 30Manufacturing | Approved | None posted |
| Oct 3, 1995 | Supplement 29Manufacturing | Approved | None posted |
| Oct 3, 1995 | Supplement 28Manufacturing | Approved | None posted |
| Apr 28, 1994 | Supplement 24Manufacturing | Approved | None posted |
| Apr 28, 1994 | Supplement 23Manufacturing | Approved | None posted |
| Apr 28, 1994 | Supplement 22Manufacturing | Approved | None posted |
| Apr 28, 1994 | Supplement 21Manufacturing | Approved | None posted |
| Jan 26, 1994 | Supplement 27Manufacturing | Approved | None posted |
| Jan 26, 1994 | Supplement 26Manufacturing | Approved | None posted |
| Jan 26, 1994 | Supplement 25Manufacturing | Approved | None posted |
| Aug 31, 1993 | Supplement 19Manufacturing | Approved | None posted |
| Aug 31, 1993 | Supplement 18Manufacturing | Approved | None posted |
| Jul 30, 1993 | Supplement 20Manufacturing | Approved | None posted |
| May 25, 1993 | Supplement 17Manufacturing | Approved | None posted |
| May 25, 1993 | Supplement 16Manufacturing | Approved | None posted |
| May 25, 1993 | Supplement 15Manufacturing | Approved | None posted |
| May 25, 1993 | Supplement 14Manufacturing | Approved | None posted |
| May 25, 1993 | Supplement 13Manufacturing | Approved | None posted |
| May 25, 1993 | Supplement 12Manufacturing | Approved | None posted |
| Apr 1, 1993 | Supplement 11Manufacturing | Approved | None posted |
| Apr 1, 1993 | Supplement 10Manufacturing | Approved | None posted |
| Apr 1, 1993 | Supplement 9Manufacturing | Approved | None posted |
| Aug 27, 1991 | Supplement 8Labeling | Approved | None posted |
| Mar 4, 1986 | Supplement 3Manufacturing | Approved | None posted |
| Mar 4, 1986 | Supplement 2Manufacturing | Approved | None posted |
| Mar 4, 1986 | Supplement 1Manufacturing | Approved | None posted |
| Dec 20, 1984 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters